| COVID 19 all comers | COVID-19 mild to moderate | COVID-19 severe or critically | ||
| COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | COVID-19 severe or critically | |
| favipiravir | IRCT20200428047228N1 // U07 Udwadia AVIFAVIR | Chang Chen et al. NCT04376814-Group A Calik NCT04310228-FAVI ... NCT04376814-Group A jRCTs041190120 Cai -FAVIPIRAVIR IRCT20150808023559N20 Cai -FAVIPIRAVIR IRCT20150808023559N20 Lou ... | Shenoy S FACCT Trial NCT04542694 Dabbous HM Holubar M Udwadia Ruzhentsova T Solaymani-Dodaran AVIFAVIR Shinkai IRCT20151227025726N14 // U07 | Kocayigit H |
| 6184 | Erdem, 2020 | 2 | 11 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 6262 | Yamamura, 2020 | 2 | 30 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 6267 | Murohashi, 2020 | 2 | 10 | 0 | excluded | not a RCT | risk of bias not avaialble |
| 6526 | Dabbous, 2021 | 2 | 1 | 3 | excluded | high risk of bias |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
